Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa.

Subjects

Subjects :

*ANTIBIOTICS
*DRUG efficacy
*INTRAVENOUS therapy
*PENICILLIN
*AMPICILLIN
*PSEUDOMONAS diseases
*PROFESSIONAL associations
*PSEUDOMONAS
*DRUG resistance in microorganisms
*MICROBIAL sensitivity tests
*PHARMACODYNAMICS
*EVALUATION

Details

Language :

English

ISSN :

10584838

Volume :

76

Issue :

10

Database :

Academic Search Index

Journal :

Clinical Infectious Diseases

Publication Type :

Academic Journal

Accession number :

163956986

Full Text :

https://doi.org/10.1093/cid/ciad012